Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents - Bog

Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Du sparer 0% ift. normalprisen Spar 0%

Paperback
8-11 hverdage
2.163,95 kr.

Bag om Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 and 28, 1988

Vis mere

Sprog:
Engelsk

ISBN:
9781461288886

Forlag:
Springer-Verlag New York Inc.

Indbinding:
Paperback

Sideantal:
298

Udgivet:
10. oktober 2011

Udgave:
11989

Størrelse:
155x235x17 mm.

Vægt:
492 g.

Leveringstid: 8-11 hverdage.
Forventet levering: 28. november 2024

På lager

Normalpris

BLACK NOVEMBER
2.163,95 kr. + Fragt
~~2.163,95 kr.~~

Medlemspris

2.113,95 kr.

Prøv i 30 dage for 45 kr.
Herefter fra 79 kr./md. Ingen binding.